You are currently viewing a new version of our website. To view the old version click .
Pathogens
  • This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
  • Review
  • Open Access

4 December 2025

Innovations in Biofilm Prevention and Eradication in Medical Sector: An Integrative Review

,
and
1
Department of Biotechnology, Microbiology and Human Nutrition, Faculty of Food Science and Biotechnology, University of Life Sciences in Lublin, Skromna 8, 20-704 Lublin, Poland
2
Research and Development Department, Margomed S.A., 16 Erazma Plewińskiego Street, 20-270 Lublin, Poland
*
Author to whom correspondence should be addressed.
Pathogens2025, 14(12), 1242;https://doi.org/10.3390/pathogens14121242 
(registering DOI)
This article belongs to the Special Issue Classic and Emerging Pathogens as a Cause of Healthcare-Associated Infections: Current Knowledge and Future Approaches

Abstract

Background: Biofilm-associated infections remain a major challenge in modern medicine due to their high resistance to antibiotics and immune defences. Advances in materials science, chemistry, and nanotechnology have led to the development of innovative, non-antibiotic approaches to prevent or eradicate biofilms. Methods: This review summarises antibiofilm strategies reported between 2020 and 2025, grouped into chemical, enzymatic, physical–photonic, nanomaterial-based, and biological hybrid categories. Results: Chemical methods such as silver-based chemical systems, nitric oxide donors, and biosurfactants disrupt bacterial membranes, generate reactive oxygen species, and inhibit quorum sensing. Enzymatic coatings with DNase I or lysostaphin effectively reduce Staphylococcus aureus and S. epidermidis biofilms, showing stability after sterilisation and high biocompatibility. Physical–photonic techniques, including photocatalytic and light-activated coatings, provide controllable and renewable antibacterial activity. Nanomaterials such as silver nanomaterials, chitosan-based carriers, magnetic ferrites, and catalytic nanozymes enable targeted, ROS-mediated biofilm disruption. Biologically derived systems, including bacteriophage hydrogels and plant metabolites, offer eco-friendly, biocompatible alternatives. Conclusions: Recent antibiofilm innovations mark a transition from conventional antibiotics to multifunctional and adaptive systems integrating chemical, enzymatic, and physical mechanisms for effective biofilm control on medical surfaces.

Article Metrics

Citations

Article Access Statistics

Article metric data becomes available approximately 24 hours after publication online.